Publications by authors named "Doug Hubatsch"

Claim this Profile
A
A phase 3 adaptive dose selection trial of NCX 470, a nitric oxide-donating bimatoprost for open-angle glaucoma or ocular hypertension: The MONT BLANC study.
Steven L Mansberger, Robert Fechtner, Krisi Lopez, Doug Hubatsch

Contemp Clin Trials· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Controlled Comparison of NCX 470, a Nitric Oxide-Donating Bimatoprost, and Latanoprost in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The MONT BLANC Study.
Robert Fechtner, Steven Mansberger, James Branch, Jay Mulaney, Sara Ziebell, Doug Hubatsch

Am J Ophthalmol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis